Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients [Phase 2]
A Phase 2 study evaluating sacituzumab govitecan in platinum-resistant ovarian cancer; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating surgery and chemotherapy with or without additional chemotherapy after surgery for ovarian, fallopian tube, uterine…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of Lorigerlimab in Participants With Advanced Solid Tumors [Phase 2]
This is a Phase 2 clinical trial update for Lorigerlimab in participants with advanced solid tumors, currently recruiting, including platinu…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy [Phase 2]
A Phase II clinical trial evaluating pembrolizumab in combination with bevacizumab and oral cyclophosphamide for high-grade ovarian cancer w…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer [Phase 1]
Phase 1 trial evaluating intraperitoneal cytokine-induced memory-like natural killer cells for recurrent ovarian cancer (including histologi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating tumor-infiltrating lymphocyte immunotherapy for multiple metastatic cancers and is currently recruiti…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC [Phase 1, Phase 2]
First-in-human Phase 1/2 trial of the NaPi2b-targeted antibody-drug conjugate TUB-040 assessing safety, PK, and preliminary efficacy in pati…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study
This document reports an ongoing clinical trial (PROVE) evaluating a polygenic risk score to predict epithelial ovarian cancer risk.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial [Phase 2]
Ongoing Phase 2 pilot clinical trial evaluating riluzole to prevent cognitive dysfunction in cancer patients undergoing chemotherapy, with m…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: IDOV-Immune for Advanced Solid Tumors [Phase 1]
This report summarizes a Phase 1 trial of IDOV-Immune from ViroMissile, Inc. for advanced solid tumors, which is currently recruiting across…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors [Phase 1, Phase 2]
AZD5335 is being studied in Phase 1/2a as both a single-agent therapy and in combination therapy for solid tumors, with recruitment ongoing.…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: D9319C00001- 1L OC Mono Global RCT [Phase 3]
Phase 3 global randomized trial of a monotherapy in first-line ovarian cancer is currently active but not recruiting. Sponsor: AstraZeneca.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluating second-look laparoscopy in women with ovarian cancer after completing their first course of chemotherapy…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
This clinical trial update describes characterizing epithelial ovarian cancer patients by homologous recombination phenotype. The study is c…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer [Phase 2]
Phase 2 trial evaluating olaparib in combination with durvalumab and UV1 for relapsed ovarian cancer; the study is currently active but not …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib [Phase 2]
A Phase 2 trial is evaluating neoadjuvant therapy for ovarian cancer using the PARP inhibitor fuzuloparib in combination with apatinib. Recr…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Video Education With Result Dependent dIsclosure [NA]
A Dana-Farber Cancer Institute clinical trial update for a study on video education with result-dependent disclosure, currently recruiting, …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery [EARLY_Phase 1]
An early-phase clinical trial is evaluating olaparib for newly diagnosed BRCA-mutant ovarian, fallopian tube, or primary peritoneal cancers …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Navigation Intervention for Adolescent and Young Adult Cancer Survivors [NA]
A Kaiser Permanente-sponsored clinical trial update describes a navigation intervention for adolescent and young adult cancer survivors. The…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3) [Phase 2]
Phase 2 trial update for ADP-A2M4CD8 TCR therapy alone and in combination with nivolumab in HLA-A2+ MAGE-A4 positive ovarian cancer (SURPASS…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Artificial Intelligence - Assisted Model for Optimal Timing of Surgery in Advanced Ovarian Cancer
A clinical trial update from Shanghai Gynecologic Oncology Group describes an active-but-not-recruiting study evaluating an AI-assisted mode…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer [Phase 1]
This clinical trial update announces the first-in-human, Phase 1 study of ATX-295, an oral inhibitor of KIF18A, in patients with advanced or…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for tegavivint in recurrent or refractory solid tumors, including lymphomas and desmoid tumors, currently …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the safety and tolerability of TransCon IL-2 β/γ alone or in combination w…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: An Exploratory Study of Detection of Endometrial and Ovarian Cancers in Vaginal Samples Retrieved by the Ellele Sampling Device [NA]
An exploratory study aims to detect endometrial and ovarian cancers in vaginal samples collected with the Ellele Sampling Device; the trial …